Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Flocor pivotal trial supported by FDA grant

Oct. 9, 1997

Mylan receives FDA approval for generic verapamil

Oct. 9, 1997

Octreotide assessed in treatment of restenosis in VERAS study

Oct. 9, 1997

GenVec/Parke-Davis collaboration focusing on angiogenic products

Oct. 8, 1997

New antiarrhythmics from American Cyanamid

Oct. 8, 1997

Key cardiovascular gene therapy patent awarded to CardioGene Therapeutics

Oct. 8, 1997

Hoechst describes Na+/H+-exchange inhibitors for ischemic disorders

Oct. 8, 1997

New discovery enhances feasibility of cardiovascular gene therapy

Oct. 8, 1997

FDA approves irbesartan for marketing

Oct. 8, 1997

Millennium and Lilly extend cardiovascular research collaboration

Oct. 7, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 30, 2026.
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Fauci’s silence may put him in contempt of Congress
BioWorld
After repeatedly invoking the Fifth Amendment to every question asked during the July 29 hearing of the U.S. Senate Homeland Security Committee, Anthony Fauci,...